Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Non Operating Investment Income: 2018-2023

Historic Non Operating Investment Income for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Dec 2023 value amounting to -$61,000.

  • Insight Molecular Diagnostics' Non Operating Investment Income fell 592.86% to -$69,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$61,000, marking a year-over-year increase of 87.05%. This contributed to the annual value of -$61,000 for FY2023, which is 87.05% up from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Non Operating Investment Income of -$61,000 as of FY2023, which was up 87.05% from -$471,000 recorded in FY2022.
  • Insight Molecular Diagnostics' Non Operating Investment Income's 5-year high stood at $297,000 during FY2020, with a 5-year trough of -$471,000 in FY2022.
  • Over the past 3 years, Insight Molecular Diagnostics' median Non Operating Investment Income value was -$61,000 (recorded in 2023), while the average stood at -$101,000.
  • Its Non Operating Investment Income has fluctuated over the past 5 years, first skyrocketed by 706.12% in 2020, then tumbled by 305.68% in 2022.
  • Yearly analysis of 5 years shows Insight Molecular Diagnostics' Non Operating Investment Income stood at -$49,000 in 2019, then skyrocketed by 706.12% to $297,000 in 2020, then dropped by 22.90% to $229,000 in 2021, then slumped by 305.68% to -$471,000 in 2022, then surged by 87.05% to -$61,000 in 2023.